eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Abbott Healthcare Products Limited

Solvay Healthcare, Mansbridge Road, West End, Southampton, SO18 3JD
Telephone: +44 (0)2380 467 000
Fax: +44 (0)2380 465 350
Medical Information e-mail: medinfo.shl@abbott.com
Customer Care direct line: +44 (0)1753 650 099
Medical Information Fax: +44 (0)2380 465 350

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 11/11/2011
PIL Klaricid Paediatric Suspension 250mg/5ml

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
Updated on 10/11/2011 and displayed until 11/11/2011
Reasons for adding or updating:
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
Updated on 16/02/2011 and displayed until 10/11/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 25/06/2010 and displayed until 16/02/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to Marketing Authorisation Holder
Updated on 28/05/2008 and displayed until 25/06/2010
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 09/04/2008 and displayed until 28/05/2008
Reasons for adding or updating:
  • Change of manufacturer
Updated on 27/09/2006 and displayed until 09/04/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to date of revision
Updated on 04/02/2002 and displayed until 27/09/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   clarithromycin